NCPA, APA join legal fight to preserve PBM-related law in Arkansas

By HME News Staff
Updated 9:52 AM CST, Mon November 10, 2025
ALEXANDRIA, Va. – The National Community Pharmacists Association (NCPA) and the Arkansas Pharmacists Association (APA) have filed a legal brief in the 8th Circuit Court of Appeals defending an Arkansas law blocking companies from operating a pharmacy benefit manager and a pharmacy in the state simultaneously. The case revolves around a state law (Act 624) passed earlier this year blocking PBMs in Arkansas from also operating pharmacies in the state. “The law protects patients by simply saying a business can either be a licensed PBM or a licensed pharmacy - but not both,” said Arkansas Pharmacists Association CEO John Vinson. “PBMs are forcing our most vulnerable Arkansans – including those battling cancer – to use pharmacies owned by or affiliated with the PBMs, and in many cases forcing them to overpay with massive markups for the medications they depend on. This blatant conflict of interest leads to dangerous delays in treatment that threaten patients’ health and safety.” NCPA, which represents nearly 19,000 independent pharmacies across the country, has been active in Arkansas and many other states supporting and defending laws that protect patient access to the pharmacies of their choice. “The Arkansas law is a model for the country,” said NCPA CEO B. Douglas Hoey. “Vertical integration has allowed a handful of giant corporations to control patients and create massive disadvantages for their competition. They deny patients the ability to choose their own health care providers, and they put a lot of small, independent pharmacies out of business, creating pharmacy deserts. The Arkansas law eliminates the obvious conflict of interest at the heart of the problem.”
Comments